MedTrace Logo

Desflurane and Sevoflurane in Pediatrics With Elevated Liver Enzymes

NCT04775212 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-10-05

No results posted yet for this study

Summary

It is designed to compare effects of inhaled anaesthetic desflurane and sevoflurane on liver functions in pediatric cancer patients

Conditions

  • Liver Functions Tests

Interventions

DRUG

Desflurane

compare effects of inhaled anaesthetic desflurane and sevoflurane on liver functions.

DRUG

Sevoflurane

Sevoflurane

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Principal Investigators

  • Suzan Adlan, MD · National Cancer Institute (NCI)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-17
Primary Completion
2021-10-17
Completion
2021-10-17

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775212 on ClinicalTrials.gov